Tuberculosis is a contagious infectious disease caused by Mycobacterium tuberculosis, an obligate intracellular bacterium that relies on infection and host-to-host transmission to survive. In a co-evolutionary process, the pathogen developed virulence mechanisms to evade the host's immune system and endure a number of factors, such as cellular stress. One of the strategies used by pathogens to succeed in causing infection is the production of proteases, which are enzymes that cleave peptide bonds between the amino acids in a protein. Proteases are widely distributed in nature and have different roles considered important to the bacteria's biological cycle. M. tuberculosis has several protease coding genes in its genome, many of which with unknown functions, but several with recognized roles in the infection process. This review presents the literature researched from 2014 to 2018 that addressed the roles of the proteases involved in M. tuberculosis infection.
INTRODUCTION
Tuberculosis (TB) is a contagious infectious disease that has smitten humanity for thousands of years. Therefore, still a global public health concern with 10 million new cases of TB registered worldwide in 2017, the equivalent of 140 cases per 100,000 inhabitants (Frieden et al., 2018) . In Brazil, in 2017, 69,569 new cases of tuberculosis were reported. The incidence coefficient was equal to 33.5 cases/100 thousand inhabitants (Brasil, 2018) . Its etiological agent, M. tuberculosis, is a primarily intracellular pathogen that is capable of successfully maintaining its viability within the host, involving a delicate interplay between the immune system and the pathogen's defenses, acquired and developed throughout thousands of years of host-pathogen interaction (Dorhoi & Kaufmann, 2016 Because M. tuberculosis infection presents a spectrum of clinical outcomes among the affected individuals, and proteases from both the host and the pathogen have been shown to play biological and physiological roles that allow the microorganism to succeed in infection, understanding the roles and functions of these enzymes, through a current literature review, will provide tools for new therapeutic strategies or options for new vaccines to improve disease control. 
MMP-2 Central Nervous System
In active TB, excess MMP-2 is probably due to secretion by microglial cells, since these are produced by monocytes and macrophages infected with M. tuberculosis.
MMP-9 Leptomeninges
The level of MMP-9 increased according to the evolution of tuberculosis raising the possibility of targeting MMP-9 as a therapeutic strategy.
METHODOLOGY
This review researched articles published over the last five years (2014 to 2018) using the keywords: M. tuberculosis, proteases, virulence and infection found in the electronic database of PubMed. Articles focusing on the M. tuberculosis proteases involved in the mechanisms of host survival/ virulence were included. Of the 30 articles found, 14 articles were excluded, since these articles were not specifically concerned with proteases involved in the infection or virulence of M. tuberculosis. Articles published prior to 2014 of seminal importance were also included.
RESULTS AND DISCUSSION

Proteases induced by M. tuberculosis involved in degradation of the cell matrix
The lung is composed of important fibrillar collagens as they provide protection against possible pathogen invasions and are highly resistant to enzymatic degradation (Elkington et al., 2011) . However, MMPs are the only known enzymes capable of cleaving the fibrillar collagen of the lung and may also be involved in remodeling and repairing various tissues. M. tuberculosis subverts the immune response of the host in its favor, leading to proteolytic destruction of the extracellular matrix. This process of degradation occurs through the regulation of the secretion of MMPs by host cells, contributing to the pathogenesis of M. tuberculosis facilitating bacillary dissemination (Ulrichs & Kaufmann., 2006) .
Among the different MMPs, MMP-1 (interstitial collagenase) plays a critical role in conducting immunopathology in active pulmonary TB during infection (Elkington et al., 2005 ). An expression of the MMP-1 gene involves the activation of activating protein 1 (AP-1), an expression factor that regulates gene expression in response to a variety of stimuli such as stress and bacterial infection. The c-Jun N-terminal kinases (JNKs) play a role in stress signaling pathways. These factors are described as being induced in response to oxidative stress (Andrade et al., 2015) . Hemeoxygenase is an important antioxidant highly expressed in the lungs and its role was potentially associated with cell protection that led Andrade et al. to a hypothesis that M. tuberculosis infection may be influenced by stress-induced HO-1 that acts on lung damage / remodeling by MMPs. It was observed that the levels of HO-1 and MMP-1 had increased in patients with active pulmonary TB possibly as a result of the interaction between host and pathogen (Andrade et al., 2015) .
Tuberculous meningitis is an infection of the leptomeninges (structures that form the meninges) basally affecting the brain. When bacilli cross the blood-brain barrier they result in tuberculomas, which rupture in the cerebral spinal fluid leading to adjacent brain structures becoming infected (Spanos et al., 2015) . During this process, the microglia cells present in the host are activated and secrete proteases capable of degrading the extracellular matrix causing tissue destruction. Among these proteases, MMPs appear to play a prominent role in tissue destruction. The level of MMP-9 increased according to the evolution of the tuberculosis raising the possibility of targeting MMP-9 as a therapeutic strategy to prevent the progression of the disease in more advanced stages. When SB-3CT or dexamethasone inhibitor drugs were used, MMP-9 levels were reduced to almost undetectable levels and the CFU count was significantly reduced by treatment with anti-tuberculosis drugs. Thus, the importance of MMP-9 in tissue destruction during tuberculous meningitis. Its inhibition may also be beneficial in the treatment of the disease (Cui et al., 2012; Majeed et al., 2016) .
In the Central Nervous System (CNS), MMP-2 degrades the basement membrane, type IV collagen and laminin. MMP-2 is constitutively expressed at high levels by many cells and is regulated by pro-peptide activation (Be et 
M. tuberculosis proteases involved in immune response modulation
Proteases secreted by the pathogen are also involved in the modulation of the immune response by M. tuberculosis. The first response generated by the host against infection is the recruitment of inflammatory cells to the lungs, followed by dissemination to the lymph nodes during the adaptive immune response (Wolf et al., 2008) . However, proteases have the ability to modulate these responses. Portugal and colleagues reported the immunomodulatory properties of a putative prolyoligopetidase POPMt (Rv0457c), classified as serine peptidase of the S9 family. This led Portugal and colleagues to evaluate the immunomodulatory properties in triggering immune responses. Peritoneal macrophages, when stimulated with POPMt for 24 hours, produced proinflammatory cytokines such as TNF, IL-12p70, IL-6, IL-23 and IL-1b, as well as chemokines such as (MCP-1) after 24h, confirming its importance during the response generated by the host (Portugal et al., 2017) .
M. tuberculosis proteases with diverse function
Several M. tuberculosis proteases that aid in the pathological process have already been described. The bacterium requires the use of lipids and host fatty acid for survival (Lee et al., 2013) . Research has shown that M. tuberculosis accumulates triacylglycerol (GAG) in hypoxic environments. These are synthesized by bacterial TAG synthase using the host-derived fatty acids (Daniel et There is evidence that in protozoa, parasites and helminths the leucyl aminopeptidases (LAPs) belonging to the M1 or M17 family of peptidases, which constitute a group of Zn-dependent metallopeptidases, play an important role in infection. An endopeptidase was described as being required for M. tuberculosis virulence as well as for its survival in macrophages. The enzyme designated as Zmp1 has homology with the human endothelin-converting enzyme. Endothelins are important peptides for constricting blood vessels and increasing blood pressure, which are considered important activities in the control of granulomas formed during TB infection. According to Correa et al. (2014) , Zmp1 (Rv0198c) showed a proteolytic activity that did not cleave the endothelin precursor (Big ET-1) to release the ET-1 peptide but was able to degrade it. The results showed that the deletion of ET-1 during infection resulted in an increase in the bacterial load and lung lesions. However, M. tuberculosis produces Zimp 1 capable of cleaving ET-1 and consequently interferes with ETA or ETB receptor signaling. Thus, a balance between ET-1 levels controlled by Zmp1 and ETA/ETB signaling may allow the adaptation and survival of M. tuberculosis in lung tissue (Singh et al., 2017) .
M. tuberculosis has to respond to a variety of stress conditions inflicted by the host, including iron limitation, reactive nitrogen and oxygen intermediates and starvation (Urban, 2009 ). These stress characteristics require signal transduction systems that transmit information within the cell. The signal transduction mechanism controls for example the availability of alternative sigma factors that direct RNA polymerase to specific promoters (Sklar et al., 2010) . Regulated intramembrane protease (RIP1) is a metalloprotease (Rv2869c) that can cleave three anti-sigma factors (i.e. anti-Sigk, anti-SigL and anti-SigM) which are negative regulators of sigma K, L, M factors, respectively. RIP-1 cleaves substrates of anti-sigma factors to control downstream pathways involved in lipid biosynthesis and protects against stress. Rip1 is required for M. tuberculosis virulence since Rip1 deletion impairs M. tuberculosis growth in mouse lungs and persistence of chronic infection (Schneider et al., 2014) .
The aminopeptidases belonging to the M17 metalloprotease family has been shown to be a potential therapeutic target (Matsui et al., 2006) . Through this information, Correa and colleagues observed that MtLAP (Rv2213) from M. tuberculosis is a metal dependent protease available in cytosol which exhibited strong sensitivity to bestatin, a strong aminopeptidase inhibitor. Testing its effect on M. tuberculosis infected macrophages, bestatin treatment strongly inhibited the bacterial growth, and, in the murine model of tuberculosis, this drug caused a reduction in bacterial load and lung injury. These effects on the growth and infection by M. tuberculosis confirm aminopetidases as a strong therapeutic potential target for the control of the disease .
Proteases involved in mycobacterial stress
M. tuberculosis has created mechanisms to assist its resistance to stress conditions, such as; acid pH, low oxygen content, low nutrient availability, reactive oxygen and nitrogen intermediates as well as other products generated by the host. These stress conditions lead to changes in protein conformation, such as; poor folding and aggregation (Rohde et al., 2007) 
Proteases involved in protein secretion and signal transduction
An important mechanism of virulence in M. tuberculosis is the ESX-1 type VII secretion system. This system transports virulence factors important for the pathogen replication in macrophages causing effects on host cells (Stanley et al., 2003) . This system has as substrates ESAT-6 and CFP-10, two proteins secreted and identified as immunodominant antigens of M. tuberculosis. The deletion of these proteins in virulent strains resulted in a decrease in their virulence, suggesting that these proteins are important for M. tuberculosis virulence. The ESAT-6 and CFP-10 proteins are encoded by the esxA (Rv3870) and esxB (3871) genes, respectively, with various activities including inhibition of phagosome maturation and cytokine signaling by infected macrophages. However, some proteins are required for their secretion such as MycP1 (Rv3883), a serine protease similar to subtilisin, which is secreted and degrades non-specific proteins. Ohol et al. demonstrated the importance of MycP1 for ESX-1 secretion in M. tuberculosis and suggestted that MycP1 has defined substrate specificity and cleaves substrates containing proline residues. MycP1 protein could perhaps be an interesting drug target for latent infection, as it is predicted to be outside the cell membrane and therefore accessible to small molecules (Ohol et al., 2010 ., van Winden et al., 2016).
Originally Hip1 was thought to be a carboxylesterase because it was unable to cleave commonly used trypsin-like protease substrates in vitro. However, a transposon mutant Hip1-KO strain was found to be deficient in proteolytic processing of the mycobacterial heat-shock protein GroEL2. A later study revealed that Hip1 protease (Rv2224c) is indeed a serine protease that can cleave GroEL2 in vitro and in vivo, resulting in the extracellular release of processed monomeric GroEL2 as a mediator of Hip1-dependent immunomodulatory activities. This serine protease associated with the cellular envelope is required for the immunomodulation of host inflammatory responses. Because of its role in mycobacterial virulence, it becomes a potential drug target. Lentz et al. demonstrated a strategy to develop chemical probes (irreversible inhibitors, ABPs and selective substrate probes) for Hip1 activity in M. tuberculosis by combining compound library selection with focus on multiple types of substrate selectivity profiles. Important determinants of the substrate were identified that are important for the recognition of Hip1, as well as a chloroisocoumarin compound that irreversibly inhibits Hip1 (Lentz et al., 2016) .
It is known that the M. tuberculosis genome encodes approximately 70 lipoproteins, many of which are important for virulence, mediating pathogen-host interactions. They are involved in various functions such as; cell wall synthesis, nutrient uptake, transmembrane signaling and adhesion, and their secretion depends on the action of signal peptidases which can be found in types I and II (Sutcliffe & Russell, 1995) . Type II signal peptidases were excluded from this analysis because they were not studied in the period comprised in this review. Type I signal peptides (Spase type I) are membrane bound endopeptidases responsible for cleaving signal peptide of secreted proteins during membrane translocation through the general secretion pathway (Sec). They are extremely important, since the cleavage of the N-terminal signal peptide allows the release of the mature protein from the cytoplasmic membrane to the external environment. An example of M. tuberculosis Spase type I is the LepB protease (Rv2903c) which plays a key role in bacterial growth. Its inhibition leads to death of both replicating and non-replicating bacteria. It has a transmembrane domain that allows its anchorage in the cytoplasmic membrane. Some potential compounds with inhibitory activity to this protease have been discovered and are promising therapeutic drugs (Ollinger et al., 2012; Bonnett et al., 2016) .
CONCLUDING REMARKS
This review has consolidated knowledge about the various proteases involved in M. tuberculosis pathogenesis which were investigated from 2014 to 2018.
